FDA grants RMAT and fast track status to Allogene's cema-cel

Go back to FDA grants RMAT and fast track status to Allogene's cema-cel
(NASDAQ: ALLO) Delayed: 1.98 -0.09 (4.35%)
Previous Close $2.07    52 Week High
Open $2.13    52 Week Low
Day High $2.16    P/E N/A 
Day Low $1.96    EPS
Volume 6,330,936